Hong Kong-based Prenetics Group Ltd. is going public on the Nasdaq Stock Market via a special-purpose acquisition company, in a deal that values the medical diagnostic startup at $1.25 billion.
Prenetics, whose revenue has surged during the coronavirus pandemic, will merge with Artisan Acquisition Corp. , a blank-check company founded by Adrian Cheng, grandson of the late Hong Kong real estate and jewelry magnateCheng Yu-tung. The younger Mr. Cheng invested in Prenetics last year and held a 0.8% stake in the startup before the latest deal.
